Brief: Acadia Pharmaceuticals Q4 EPS USD 1.6
25/02/2026 21:05
Feb 25 (Reuters) - Acadia Pharmaceuticals Q4 operating expenses USD 266.598 million. Q4 product sales USD 283.989 million Q4 net income USD 273.568 million Q4 pretax profit USD 26.319 million
Recent news on Acadia Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-FactSet, Moderna, Goldman Sachs
U.S. STOCKS ON THE MOVE-Biogen, Incyte, Quantum Cyber
U.S. STOCKS ON THE MOVE-Fortrea, Nuvation Bio, Acadia Pharmaceuticals
Acadia Pharma jumps after EU panel reverses opinion on neurological disorder drug
Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP